Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The primary objective was to determine whether this intervention would decrease the risk of incident tuberculosis (TB) infection, as indicated by the conversion of an interferon-gamma release assay from negative at baseline to positive at 3-year follow-up; null findings for this outcome have been reported elsewhere.23 The current paper reports findings of a substudy nested within the main trial, which tested the hypotheses that vitamin D supplementation would improve grip strength, standing long jump distance, peak oxygen uptake (VO2peak) and reduce risk of EIB in a subset of 450 participants aged 8 to 11 years at baseline.
Source: Introduction. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Influence of vitamin D supplementation on muscle strength and exercise capacity in South African schoolchildren: secondary outcomes from a randomised controlled trial (ViDiKids)
Source: Article title.
Parents or legal guardians were invited to provide written informed consent for their child to participate in the main trial during a home visit, unless their child was eligible for the substudy, in which case they were invited to provide written informed consent for their child to participate in both the main trial and the substudy until a total of 450 substudy participants were randomised.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Influence of vitamin D supplementation on muscle strength and exercise capacity in South African schoolchildren: secondary outcomes from a randomised controlled trial (ViDiKids)
Randomised controlled trial · BMJ Open Sport & Exercise Medicine · 2024
Original publication title
Influence of vitamin D supplementation on muscle strength and exercise capacity in South African schoolchildren: secondary outcomes from a randomised controlled trial (ViDiKids)
Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To determine whether vitamin D supplementation influences grip strength, explosive leg power, cardiorespiratory fitness and risk of exercise-induced bronchoconstriction (EIB) in South African schoolchildren.
Source: ObjectiveAbstract: What methods does the paper describe?
Substudy (n=450) in Cape Town schoolchildren aged 8 to 11 years nested within a phase 3 randomised placebo-controlled trial (ViDiKids). The intervention was weekly oral doses of 10 000 IU vitamin D3 (n=228) or placebo (n=222) for 3 years. Outcome measures were serum 25-hydroxyvitamin D3 (25(OH)D3) concentrations, grip strength, standing long jump distance, peak oxygen uptake (VO2peak, determined using 20 m multistage shuttle run tests) and the proportion of children with EIB, measured at end-study.
Source: MethodsAbstract: Results
64.7% of participants had serum 25(OH)D3concentrations <75 nmol/L at baseline. At 3-year follow-up, children randomised to vitamin D versus placebo had higher mean serum 25(OH)D3 concentrations (97.6 vs 58.8 nmol/L, respectively; adjusted mean difference 39.9 nmol/L, 95% CI 36.1 to 43.6). However, this was not associated with end-study differences in grip strength, standing long jump distance, VO2peak or risk of EIB.
Source: ResultsAbstract: Conclusion
A 3-year course of weekly oral supplementation with 10 000 IU vitamin D3 elevated serum 25(OH)D3 concentrations in South African schoolchildren but did not influence muscle strength, exercise capacity or risk of EIB.
Source: ConclusionAuthors’ abstract
Abstract
Objective
To determine whether vitamin D supplementation influences grip strength, explosive leg power, cardiorespiratory fitness and risk of exercise-induced bronchoconstriction (EIB) in South African schoolchildren.
Methods
Substudy (n=450) in Cape Town schoolchildren aged 8 to 11 years nested within a phase 3 randomised placebo-controlled trial (ViDiKids). The intervention was weekly oral doses of 10 000 IU vitamin D3 (n=228) or placebo (n=222) for 3 years. Outcome measures were serum 25-hydroxyvitamin D3 (25(OH)D3) concentrations, grip strength, standing long jump distance, peak oxygen uptake (VO2peak, determined using 20 m multistage shuttle run tests) and the proportion of children with EIB, measured at end-study.
Results
64.7% of participants had serum 25(OH)D3concentrations <75 nmol/L at baseline. At 3-year follow-up, children randomised to vitamin D versus placebo had higher mean serum 25(OH)D3 concentrations (97.6 vs 58.8 nmol/L, respectively; adjusted mean difference 39.9 nmol/L, 95% CI 36.1 to 43.6). However, this was not associated with end-study differences in grip strength, standing long jump distance, VO2peak or risk of EIB.
Conclusion
A 3-year course of weekly oral supplementation with 10 000 IU vitamin D3 elevated serum 25(OH)D3 concentrations in South African schoolchildren but did not influence muscle strength, exercise capacity or risk of EIB.
Publication and source details
Original title: Influence of vitamin D supplementation on muscle strength and exercise capacity in South African schoolchildren: secondary outcomes from a randomised controlled trial (ViDiKids)
Keren Middelkoop; Lisa Micklesfield; Stephanie Hemmings; Neil Walker; Justine Stewart; David A Jolliffe; Amy E Mendham; Jonathan C Y Tang; Cyrus Cooper; Nicholas C Harvey; Robert J Wilkinson; Adrian R Martineau
BMJ Open Sport & Exercise Medicine · 2024
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
Additional supplemental material is published online only. To view, please visit the journal online (https://doi.org/10.1136/bmjsem-2024-002019).
ARM declares receipt of funding in the last 36 months to support vitamin D research from the following companies who manufacture or sell vitamin D supplements: Pharma Nord, DSM Nutritional Products, Thornton & Ross and Hyphens Pharma. ARM also declares receipt of vitamin D capsules for clinical trial use from Pharma Nord, Synergy Biologics and Cytoplan; support for attending meetings from Pharma Nord Ltd and Abiogen Pharma; receipt of consultancy fees from DSM Nutritional Products and Qiagen; receipt of a speaker fee from the Linus Pauling Institute; participation on Data and Safety Monitoring Boards for the VITALITY trial (Vitamin D for Adolescents with HIV to reduce musculoskeletal morbidity and immunopathology, Pan African Clinical Trials Registry ref PACTR20200989766029) and the Trial of Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India (ClinicalTrials.gov ref NCT04641195) and unpaid work as a Programme Committee member for the Vitamin D Workshop.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T03:37:47.785327+00:00
DOI: 10.1136/bmjsem-2024-002019 · PMC11429360